Gerco den Hartog

National Institute for Public Health and the Environment (RIVM) - Department of Immune Surveillance

SCHOLARLY PAPERS

5

DOWNLOADS

560

SSRN CITATIONS

0

CROSSREF CITATIONS

0

Scholarly Papers (5)

1.

Tolerability, Safety and Immunogenicity of Intradermal Delivery of a Fractional Dose mRNA -1273 SARS-CoV-2 Vaccine in Healthy Adults as a Dose Sparing Strategy

Number of pages: 22 Posted: 27 Jul 2021
Leiden University - Department of Parasitology, Leiden University - Department of Infectious Diseases, National Institute for Public Health and the Environment (RIVM) - Department for Immunology of Infectious Diseases and Vaccination (IIV), National Institute for Public Health and the Environment (RIVM) - Department of Immune Surveillance, Leiden University - Department of Parasitology, Leiden University - Department of Infectious Diseases, Leiden University - Department of Parasitology, Leiden University - Department of Infectious Diseases, Leiden University - Department of Medical Microbiology, National Institute for Public Health and the Environment (RIVM) - Department of Immune Surveillance, Leiden University - Department of Clinical Epidemiology, Leiden University - Department of Parasitology, Leiden University - Department of Infectious Diseases and Leiden University - Department of Infectious Diseases
Downloads 254 (225,805)
Citation 9

Abstract:

Loading...

2.

Serological Evidence for Reinfection with SARS-CoV-2; An Observational Cohort Study

Number of pages: 17 Posted: 08 Mar 2021
National Institute for Public Health and the Environment (RIVM) - Department for Immunology of Infectious Diseases and Vaccination (IIV), National Institute for Public Health and the Environment (RIVM) - Department of Immune Surveillance, National Institute for Public Health and the Environment (RIVM), National Institute for Public Health and the Environment (RIVM) - Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), National Institute for Public Health and the Environment (RIVM), National Institute for Public Health and the Environment (RIVM) - WHO Reference Laboratory for COVID-19, National Institute for Public Health and the Environment (RIVM) - Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM) - Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM) and National Institute for Public Health and the Environment (RIVM)
Downloads 118 (437,749)

Abstract:

Loading...

3.

Fourth mRNA COVID-19 Vaccination in Immunocompromised Patients with Hematologic Malignancies

Number of pages: 23 Posted: 06 Mar 2023
University of Amsterdam, Academic Medical Center, Department of Hematology, University of Amsterdam, Academic Medical Center, Department of Hematology, University of Amsterdam - Department of Clinical Epidemiology, Biostatistics and Bioinformation, Erasmus University Rotterdam (EUR) - Department of Hematology, University of Groningen - Department of Hematology and Oncology, National Institute for Public Health and the Environment (RIVM) - Department for Immunology of Infectious Diseases and Vaccination (IIV), National Institute for Public Health and the Environment (RIVM) - Department of Immune Surveillance, University of Amsterdam, Academic Medical Center, Department of Hematology, University of Amsterdam - Amsterdam Institute for Infection and Immunity, Vrije Universiteit Amsterdam - Department of Hematology, University of Amsterdam - Amsterdam Institute for Infection and Immunity, University of Amsterdam - Amsterdam Institute for Infection and Immunity, National Institute of Public Health and the Environment, University of Amsterdam - Central Diagnostic Laboratory, University of Amsterdam - Amsterdam Institute for Infection and Immunity, Free University, Amsterdam - Medical Immunology Laboratory, University of Amsterdam - Amsterdam Institute for Infection and Immunity, Netherlands Comprehensive Cancer Organisation, National Institute for Public Health and the Environment (RIVM) - Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM) - Department for Immunology of Infectious Diseases and Vaccination (IIV), Leiden University, Medical Center (LUMC), Department of Hematology, Vrije Universiteit Amsterdam - Department of Hematology, University of Groningen - Department of Hematology and Oncology, Erasmus University Rotterdam (EUR) - Department of Hematology, University of Amsterdam - Department of Medical Microbiology and Infection Prevention, University of Amsterdam - Department of Infectious Diseases, University of Amsterdam, Academic Medical Center, Department of Hematology, University of Amsterdam, Academic Medical Center, Department of Hematology, Vrije Universiteit Amsterdam - Department of Hematology and Independent
Downloads 77 (579,877)

Abstract:

Loading...

Humoral immunogenicity, Antibody response, SARS-CoV-2, COVID-19 vaccination, Booster vaccination, Hematologic malignancies, Immunocompromised

4.

Antibody and T-Cell Responses 6 Months after Covid-19 mRNA-1273 Vaccination in Patients with Chronic Kidney Disease, on Dialysis, or Living with a Kidney Transplant

Number of pages: 32 Posted: 30 Mar 2022
University of Groningen - Division of Nephrology, University of Groningen - Division of Nephrology, Erasmus University Rotterdam (EUR) - Department of Viroscience, Erasmus University Rotterdam (EUR) - Department of Internal Medicine, Nephrology and Transplantation, University of Groningen - Department of Medical Microbiology and Infection Prevention, National Institute for Public Health and the Environment (RIVM) - Department for Immunology of Infectious Diseases and Vaccination (IIV), Radboud University Nijmegen - Radboud University Medical Center, Erasmus University Rotterdam (EUR) - Department of Viroscience, Erasmus University Rotterdam (EUR) - Department of Viroscience, Erasmus Medical Center - Viroscience Department, National Institute for Public Health and the Environment (RIVM) - Department of Immune Surveillance, Erasmus University Rotterdam (EUR) - Department of Internal Medicine, Nephrology and Transplantation, Erasmus University Rotterdam (EUR) - Department of Viroscience, Radboud University Nijmegen - Radboud University Medical Center, University of Amsterdam - Department of Experimental Immunology, National Institute for Public Health and the Environment (RIVM) - Centre for Infectious Disease Control, University of Groningen - Division of Nephrology, University of Amsterdam - Department of Internal Medicine, Radboud University Nijmegen - Radboud University Medical Center, Erasmus University Rotterdam (EUR) - Department of Internal Medicine, Nephrology and Transplantation and Independent
Downloads 67 (625,508)
Citation 3

Abstract:

Loading...

COVID-19, mRNA-1273, vaccine, chronic kidney disease, kidney transplantation, dialysis, immunogenicity

5.

Alternative Strategies to Increase the Immunogenicity of Covid-19 Vaccines in Kidney Transplant Recipients Not Responding to Two or Three Doses of an mRNA Vaccine. A Randomized Clinical Trial

Number of pages: 31 Posted: 29 Jul 2022
Erasmus University Rotterdam (EUR) - Department of Internal Medicine, Nephrology and Transplantation, University of Groningen - Division of Nephrology, University of Amsterdam - Renal Transplant Unit, University of Groningen - Division of Nephrology, Radboud University Nijmegen - Department of Nephrology, Erasmus University Rotterdam (EUR) - Department of Internal Medicine, Nephrology and Transplantation, Erasmus University Rotterdam (EUR) - Department of Viroscience, Erasmus University Rotterdam (EUR) - Department of Internal Medicine, Nephrology and Transplantation, Radboud University Nijmegen - Radboud University Medical Center, Radboud University Nijmegen - Radboud University Medical Center, University of Amsterdam - Department of Experimental Immunology, University of Groningen - Department of Medical Microbiology and Infection Prevention, National Institute for Public Health and the Environment (RIVM) - Department for Immunology of Infectious Diseases and Vaccination (IIV), National Institute for Public Health and the Environment (RIVM) - Department of Immune Surveillance, University of Groningen - Division of Nephrology, University of Amsterdam - Department of Internal Medicine, Erasmus University Rotterdam (EUR) - Department of Internal Medicine, Nephrology and Transplantation, University of Groningen - Division of Nephrology, Radboud University Nijmegen - Radboud University Medical Center and Independent
Downloads 44 (759,201)
Citation 4

Abstract:

Loading...

COVID-19, mRNA-1273, Ad26.COV2-S, Vaccine, kidney transplantation, immunogenicity